Invokana Lawsuits contributing to a burgeoning MDL

Invokana Lawsuits contributing to a burgeoning MDL

Introduction

An Invokana lawsuit was filed by a man from Illinois alleging that the side effects of this antidiabetic drug resulted in the amputation of his big toe, thereby holding the manufacturers responsible for failing to adequately warn the users and medical community about the risk.

Another Invokana lawsuit was filed by a man from Florida who had to amputate his second right toe due to ongoing ulceration and osteomyelitis, leaving him permanently disfigured. This was less than a year after he was first prescribed Invokana for treatment of type 2 diabetes. This case too shall soon join the Invokana lawsuits pending in the New Jersey federal court.

Invokana: MDL 2750, in re: Invokana (Canagliflozin) Products Liability Litigation) was created in December 2016, presided by Hon. Brian R. Martinotti, in the U.S. District Court for the District of New Jersey; the first bellwether is scheduled for September 2018. Cases are also filed in state courts, primarily in California, Pennsylvania, and New Jersey. There are more than 1,000 Invokana lawsuits currently pending the federal MDL and are in the pretrial discovery phase.